Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
, Klinik für Hämatologie
Aktuelle Veranstaltungen
-
2022 SS
Vergangene Veranstaltungen (max. 10)
-
2021 WS
-
2021 SS
-
2020 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Acquired aplastic anemia following SARS-CoV-2 vaccinationIn: European Journal of Haematology (2022) in press
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ (Open Access) -
Complement-mediated hemolysis persists year round in patients with cold agglutinin diseaseIn: Transfusion Jg. 62 (2022) Nr. 1, S. 51 - 59
ISSN: 1537-2995; 0041-1132Online Volltext: dx.doi.org/ (Open Access) -
Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism : Subanalysis of the phase 1/2 COMPOSER studyIn: British Journal of Haematology (2022)
ISSN: 1365-2141; 0007-1048Online Volltext: dx.doi.org/ (Open Access) -
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma : 7-year results of the IELSG32 randomized trialIn: Leukemia (2022) in press
ISSN: 1476-5551; 0887-6924Online Volltext: dx.doi.org/ -
Characterization of breakthrough hemolysis events observed in the phase III randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuriaIn: Haematologica / The Hematology Journal Jg. 106 (2021) Nr. 1, S. 230 - 237
ISSN: 1592-8721; 0390-6078Online Volltext: dx.doi.org/ (Open Access) -
Dynamics of mutations in patients with essential thrombocythemia treated with imetelstatIn: Haematologica Jg. 106 (2021) Nr. 9, S. 2397 - 2404
ISSN: 1592-8721; 0390-6078Online Volltext: dx.doi.org/ (Open Access) -
One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumabIn: European Journal of Haematology Jg. 106 (2021) Nr. 3, S. 389 - 397
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ (Open Access) -
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal HemoglobinuriaIn: The New England Journal of Medicine Jg. 384 (2021) Nr. 11, S. 1028 - 1037
ISSN: 1533-4406; 0028-4793Online Volltext: dx.doi.org/ -
Pregnancies and neonatal outcomes in patients with sickle cell disease (SCD) : Still a (high-)risk constellation?In: Journal of Personalized Medicine Jg. 11 (2021) Nr. 9,
ISSN: 2075-4426Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Sutimlimab in cold agglutinin diseaseIn: The New England Journal of Medicine Jg. 384 (2021) Nr. 14, S. 1323 - 1334
ISSN: 1533-4406; 0028-4793Online Volltext: dx.doi.org/ -
Targeting telomere biology in acute lymphoblastic leukemiaIn: International Journal of Molecular Sciences (IJMS) Jg. 22 (2021) Nr. 13,
ISSN: 1422-0067; 1661-6596Online Volltext: dx.doi.org/ (Open Access) -
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH) : updated analysis from the International PNH RegistryIn: Annals of Hematology Jg. 99 (2020) S. 1505 - 1514
ISSN: 1432-0584; 0939-5555; 0006-5242Online Volltext: dx.doi.org/ (Open Access) -
Beneficial effects of eculizumab regardless of prior transfusions or bone marrow disease : Results of the International Paroxysmal Nocturnal Hemoglobinuria RegistryIn: European Journal of Haematology Jg. 105 (2020) Nr. 5, S. 561 - 570
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ (Open Access) -
Diagnosis and treatment of autoimmune hemolytic anemia in adults : Recommendations from the First International Consensus MeetingIn: Blood Reviews Jg. 41 (2020) S. 100648
ISSN: 0268-960X; 1532-1681Online Volltext: dx.doi.org/ (Open Access) -
Do temperature and time matter in cold agglutinin disease?In: Blood Jg. 136 (2020) Nr. 4, S. 380 - 381
ISSN: 1528-0020Online Volltext: dx.doi.org/ (Open Access) -
Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor : A Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow TransplantationIn: Haematologica / The Hematology Journal Jg. 105 (2020) Nr. 5, S. 1223 - 1231
ISSN: 1592-8721; 0390-6078Online Volltext: dx.doi.org/ (Open Access) -
Mutations in PIGA cause a CD52-/GPI-anchor-deficient phenotype complicating alemtuzumab treatment in T-cell prolymphocytic leukemiaIn: European Journal of Haematology Jg. 105 (2020) Nr. 6, S. 786 - 796
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ (Open Access) -
No evidence for hypogammaglobulinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with ravulizumabIn: PLoS ONE Jg. 15 (2020) Nr. 3,
ISSN: 1932-6203Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuriaIn: PLoS ONE Jg. 15 (2020) Nr. 9, S. e0237497
ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access) -
Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia–Paroxysmal Nocturnal Hemoglobinuria : A High-Risk ConstellationIn: Frontiers in Medicine Jg. 7 (2020) S. 543372
ISSN: 2296-858XOnline Volltext: dx.doi.org/ Online Volltext (Open Access) -
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuriaIn: Blood Jg. 135 (2020) Nr. 12, S. 912 - 920
ISSN: 1528-0020Online Volltext: dx.doi.org/ (Open Access) -
Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome : a Single-Center ExperienceIn: Hemoglobin Jg. 44 (2020) Nr. 2, S. 71 - 77
ISSN: 1532-432X; 0363-0269Online Volltext: dx.doi.org/ -
Cold agglutinin disease : current challenges and future prospectsIn: Journal of Blood Medicine Jg. 10 (2019) S. 93 - 103
ISSN: 1179-2736Online Volltext: dx.doi.org/ (Open Access) -
Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)—a report on phase IIIIn: Annals of Hematology Jg. 98 (2019) Nr. 7, S. 1547 - 1559
ISSN: 1432-0584; 0939-5555; 0006-5242Online Volltext: dx.doi.org/ (Open Access) -
Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH RegistryIn: American Journal of Hematology Jg. 94 (2019) Nr. 1, S. E37 - E41
ISSN: 1096-8652; 0361-8609Online Volltext: dx.doi.org/ (Open Access) -
Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA) : A single-center experience over the past 15 yearsIn: European Journal of Haematology Jg. 103 (2019) Nr. 1, S. 18 - 25
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ -
Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin diseaseIn: Blood Advances Jg. 3 (2019) Nr. 20, S. 2980 - 2985
ISSN: 2473-9537; 2473-9529Online Volltext: dx.doi.org/ (Open Access) -
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH : the 302 studyIn: Blood Jg. 133 (2019) Nr. 6, S. 540 - 549
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Serologic response to meningococcal vaccination in patients with cold agglutinin disease (CAD) in the novel era of complement inhibitionIn: Vaccine Jg. 37 (2019) Nr. 44, S. 6682 - 6687
ISSN: 1873-2518; 0264-410X; 1358-8745Online Volltext: dx.doi.org/ -
Eculizumab in cold agglutinin disease (DECADE) : an open-label, prospective, bicentric, nonrandomized phase 2 trial.In: Blood Advances Jg. 2 (2018) Nr. 19, S. 2543 - 2549
ISSN: 2473-9537; 2473-9529Online Volltext: dx.doi.org/ (Open Access) -
Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria : results of 2 phase 1b/2 studiesIn: Blood Advances Jg. 2 (2018) Nr. 17, S. 2176 - 2185
ISSN: 2473-9537; 2473-9529Online Volltext: dx.doi.org/ (Open Access) -
Screening and diagnostic clinical algorithm for paroxysmal nocturnal hemoglobinuria : Expert consensusIn: European Journal of Haematology Jg. 101 (2018) Nr. 1, S. 3 - 11
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ -
Seasonal Patterns of Anemia, Hemolytic Markers and Healthcare Resource Utilization Among Patients with Cold Agglutinin Disease in the United States : A Retrospective Analysis
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 4873 - 4873
ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/ (Open Access) -
The Role of Whole-Body Magnetic Resonance Imaging (WB-MRI) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).In: Scientific Reports Jg. 8 (2018) S. 13458
ISSN: 2045-2322Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Autologous stem cell transplantation (ASCT) or whole-brain radiotherapy (WBRT) as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with newly diagnosed primary cns lymphoma (PCNSL) : results of the IELSG32 randomizIn: Bone Marrow Transplantation Jg. 52 (2017) Nr. Suppl. 1, S. 96
ISSN: 0268-3369 -
Cytopenia first - hepatitis second : an unusual sequence in aplastic anemiaIn: Clinical Case Reports Jg. 5 (2017) Nr. 6, S. 778 - 781
ISSN: 2050-0904Online Volltext: dx.doi.org/ (Open Access) -
Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH) : report on phases I and IIIn: Annals of Hematology Jg. 96 (2017) Nr. 2, S. 171 - 181
ISSN: 1432-0584; 0939-5555; 0006-5242Online Volltext: dx.doi.org/ (Open Access) -
Development of a screening and diagnostic algorithm for paroxysmal nocturnal hemoglobinuria using a modified delphi panel methodologyIn: Haematologica Jg. 102 (2017) Nr. S2, S. 224 - 225
ISSN: 0390-6078; 1592-8721 -
Heterozygous RTEL1 variants are associated with bone marrow failure in cryptic dyskeratosis congenita - first results from the Aachen telomere registryIn: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 252
ISSN: 2296-5270Online Volltext: dx.doi.org/ -
High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma : a prospective multicentre trial by the German Cooperative PCNSL study groupIn: Leukemia Jg. 31 (2017) Nr. 12, S. 2623 - 2629
ISSN: 1476-5551Online Volltext: dx.doi.org/ -
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)In: Leukemia Jg. 31 (2017) Nr. 4, S. 846 - 852
ISSN: 1476-5551; 0887-6924Online Volltext: dx.doi.org/ (Open Access) -
Persisting hyperbilirubinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with eculizumab : The role of hepatocanalicular transporter variantsIn: European Journal of Haematology Jg. 99 (2017) Nr. 4, S. 350 - 356
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ -
Response to anti-thymocyte globulin (ATG) in patients with Aplastic Anemia (AA) : a single-centre experience over the last 28 yearsIn: Haematologica Jg. 102 (2017) Nr. Suppl. 2, S. 226
ISSN: 0390-6078; 1592-8721 -
Response to anti-thymocyte globulin (ATG) in patients with Aplastic Anemia (AA) : a single-centre experience over the last 28 yearsIn: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 31
ISSN: 2296-5270Online Volltext: dx.doi.org/ -
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumabIn: Annals of Hematology Jg. 96 (2017) Nr. 4, S. 589 - 596
ISSN: 1432-0584; 0939-5555; 0006-5242Online Volltext: dx.doi.org/ -
Telomere lenght screening triggered by clinical suspicion for classical and/or cryptic dyskeratosis congenita - prospective results from the Aachen Telomeropathy RegistryIn: Haematologica Jg. 102 (2017) Nr. Suppl. 2, S. 62
ISSN: 0390-6078; 1592-8721 -
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma : results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trialIn: The Lancet: Haematology Jg. 4 (2017) Nr. 11, S. e510 - e523
ISSN: 2352-3026Online Volltext: dx.doi.org/ -
Aortic thrombosis leading to the diagnosis of Paroxysmal Nocturnal Hemoglobinuria (PNH)In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 62 - 62
ISSN: 2296-5270; 2296-5262 -
Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories : an analysis of the International PNH RegistryIn: Internal Medicine Journal Jg. 46 (2016) Nr. 9, S. 1044 - 1053
ISSN: 1444-0903; 1445-5994Online Volltext: dx.doi.org/ -
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma : A prospective, single-arm, phase 2 trialIn: The Lancet Haematology Jg. 3 (2016) Nr. 8, S. e388 - e397
ISSN: 2352-3026Online Volltext: dx.doi.org/ -
Horse anti-thymocyte globulin and eculizumab as concomitant therapeutic approach in an aplastic paroxysmal nocturnal hemoglobinuria patient : go or no-go?In: European Journal of Haematology Jg. 97 (2016) Nr. 4, S. 403 - 405
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ -
Infection control with granulocyte transfusions in very severe aplastic anemia (VSAA)In: Oncology Research and Treatment Jg. 39 3 (2016) S. 62
ISSN: 2296-5270; 2296-5262 -
Shorter telomeres correlate with an increase in the number of uniparental disomies in patients with chronic lymphocytic leukemiaIn: Leukemia and Lymphoma Jg. 57 (2016) Nr. 3, S. 590 - 595
ISSN: 1029-2403Online Volltext: dx.doi.org/ -
The terminal complement inhibitor eculizumab in Cold Agglutinin Disease (CAD) : A prospective phase II trial (DECADE Trial)In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 138 - 138
ISSN: 2296-5270; 2296-5262 -
Complement Inhibition with Eculizumab in Patients with Cold Agglutinin Disease (CAD) : Results from a Prospective Phase II Trial (DECADE Trial)In: Blood Jg. 126 (2015) Nr. 23, S. 274
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ Online Volltext -
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal HemoglobinuriaIn: The New England Journal of Medicine Jg. 373 (2015) Nr. 11, S. 1032 - 1039
ISSN: 1533-4406; 0028-4793Online Volltext: dx.doi.org/ (Open Access) -
How to manage patients with hereditary haemorrhagic telangiectasiaIn: British Journal of Haematology Jg. 171 (2015) Nr. 4, S. 443 - 452
ISSN: 0007-1048; 1365-2141Online Volltext: dx.doi.org/ -
Paroxysmal nocturnal haemoglobinuria : to prednisone or not to prednisone? A case report of a patient previously treated with steroids for 15 yrs and significant response on eculizumabIn: European Journal of Haematology Jg. 95 (2015) Nr. 2, S. 177 - 180
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ -
Prognostic impact of intraocular involvement in primary CNS lymphoma : experience from the G-PCNSL-SG1 trialIn: Annals of Hematology Jg. 94 (2015) Nr. 3, S. 409 - 414
ISSN: 1432-0584; 0939-5555; 0006-5242Online Volltext: dx.doi.org/ -
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphomaIn: Neurology Jg. 84 (2015) Nr. 12, S. 1242 - 1248
ISSN: 0028-3878; 1526-632XOnline Volltext: dx.doi.org/; Online Volltext: dx.doi.org/ (Open Access) -
Telomerase Inhibitor Imetelstat in Patients with Essential ThrombocythemiaIn: The New England Journal of Medicine Jg. 373 (2015) Nr. 10, S. 920 - 928
ISSN: 1533-4406; 0028-4793Online Volltext: dx.doi.org/; Online Volltext: dx.doi.org/ (Open Access) -
Update on paroxysmal nocturnal haemoglobinuria : On the long way to understand the principles of the diseaseIn: European Journal of Haematology Jg. 94 (2015) Nr. 6, S. 464 - 473
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ -
At-59-high-dose MTX-based chemotherapy for primary CNS lymphoma : with or without whole brain radiotherapy? : final analysis of G-PCNSL-SG-1In: Neuro-Oncology Jg. 16 (2014) Nr. Suppl.5, S. v21 - v22
ISSN: 1522-8517; 1523-5866Online Volltext: dx.doi.org/ -
Selten aber wichtig : Paroxysmale nächtliche Hämoglobinurie (PNH)In: Nieren- und Hochdruckkrankheiten Jg. 43 (2014) Nr. 6, S. 281 - 285
ISSN: 0300-5224 -
Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1(+) effector memory phenotypeIn: Cancer Immunology, Immunotherapy Jg. 62 (2013) Nr. 11, S. 1697 - 1709
ISSN: 0340-7004; 1432-0851Online Volltext: dx.doi.org/ -
Hand-foot syndrome : common presentation in an uncommon situationIn: European Journal of Haematology Jg. 91 (2013) Nr. 5, S. 472
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ -
Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuriaIn: British Journal of Haematology Jg. 162 (2013) Nr. 1, S. 62 - 73
ISSN: 0007-1048; 1365-2141Online Volltext: dx.doi.org/ (Open Access) -
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomasIn: Haematologica Jg. 98 (2013) Nr. 3, S. 364 - 370
ISSN: 0390-6078; 1592-8721Online Volltext: dx.doi.org/ (Open Access) -
Successful treatment of a patient with refractory aquired hemophilia A (AHA) lacking aPTT prolongation with rituximab and intravenous cyclophosphamideIn: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 243
ISSN: 0378-584X; 1423-0240 -
CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasmsIn: Leukemia Research Jg. 36 (2012) Nr. 9, S. 1204 - 1207
ISSN: 0145-2126; 1873-5835Online Volltext: dx.doi.org/ -
Chronic lymphocytic leukemia gone osteolytic : a case reportIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 217 - 218
ISSN: 0378-584X; 1423-0240 -
Fate of GPI-deficient clones in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) : a retrospective analysisIn: Onkologie Jg. 35 (2012) Nr. 6, S. 24
ISSN: 0378-584X; 1423-0240 -
Imetelstat Rapidly Induces and Maintains Substantial Hematologic and Molecular Responses in Patients with Essential Thrombocythemia (ET) Who Are Refractory or Intolerant to Prior Therapy : Preliminary Phase II ResultsIn: Blood Jg. 120 (2012) Nr. 21, -
ISSN: 0006-4971; 1528-0020 -
Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trialIn: Neurology Jg. 79 (2012) Nr. 9, S. 890 - 896
ISSN: 0028-3878; 1526-632XOnline Volltext: dx.doi.org/ -
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL) : experience from the G-PCNSL-SG1 trialIn: Annals of Oncology Jg. 23 (2012) Nr. 9, S. 2374 - 2380
ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ (Open Access) -
Sequential High Dose Immuno-Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with Untreated Primary Central Nervous System Lymphoma - a Multicentre Study by the Collaborative PCNSL Study Group FreiburgIn: Blood Jg. 120 (2012) Nr. 21, -
ISSN: 0006-4971; 1528-0020 -
Significance of chromosomal aberrations and HMGA2 expression in Paroxysmal Nocturnal Hemoglobinuria (PNH)In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 220 - 221
ISSN: 0378-584X; 1423-0240 -
Acral ischemia as a presenting manifestation of essential thrombocythemiaIn: International Journal of Hematology Jg. 94 (2011) Nr. 3, S. 219 - 220
ISSN: 1865-3774; 0925-5710Online Volltext: dx.doi.org/ -
Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab : safety, efficacy, and unexpected laboratory phenomenaIn: International Journal of Hematology Jg. 93 (2011) Nr. 6, S. 704 - 714
ISSN: 1865-3774; 0925-5710Online Volltext: dx.doi.org/ -
Empfehlungen zur Diagnostik der Paroxysmalen nächtlichen Hämoglobinurie : deutsch – österreichischer KonsensusIn: Laboratoriumsmedizin Jg. 35 (2011) Nr. 6, S. 315 - 327
ISSN: 0342-3026; 1439-0477; 2567-9449; 2567-9430Online Volltext: dx.doi.org/ -
Impact of meningeal dissemination (MD) on outcome in primary CNS lymphoma in the G-PCNSL-SG1 trialIn: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 2026
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Prognostic factors for chemotherapy-related toxicity in primary central nervous system lymphoma (PCNSL) treated with high-dose methotrexate (HDMTX) with or without ifosfamide: Results from a German phase III trial (G-PCNSL-SG-1)In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 2005
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Prognostic factors for response and survival in primary central nervous system lymphoma (PCNSL) from a randomized phase III trial (G-PCNSL-SG-1)In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 2004
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Telomeres and prognosis in patients with chronic lymphocytic leukaemiaIn: International Journal of Hematology Jg. 93 (2011) Nr. 1, S. 74 - 82
ISSN: 1865-3774Online Volltext: dx.doi.org/ -
Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumabIn: European Journal of Haematology Jg. 87 (2011) Nr. 6, S. 473 - 479
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ -
Amyloid tumourIn: British Journal of Haematology Jg. 150 (2010) Nr. 4, S. 387
ISSN: 0007-1048; 1365-2141Online Volltext: dx.doi.org/ -
Cold agglutinine diseaseIn: European Journal of Haematology Jg. 84 (2010) Nr. 1, S. 91
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ -
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1) : a phase 3, randomised, non-inferiority trialIn: The Lancet Oncology Jg. 11 (2010) Nr. 11, S. 1036 - 1047
ISSN: 1470-2045; 1474-5488Online Volltext: dx.doi.org/ -
Inhibition of the Terminal Complement System Using Eculizumab for the Treatment of Cold Agglutinin Disease (CAD)
184. Tagung der Rheinisch-Westfälischen Gesellschaft für Innere Medizin e.V.,In: Medizinische Klinik Jg. 105 (2010) Nr. 3, S. 213 - 214
ISSN: 0723-5003; 2193-6218; 2193-6226; 1615-6722Online Volltext: dx.doi.org/ -
Intraperitoneal and intrapleural application of Rituximab in refractory CD20-positive B-cell lymphoma
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 253
ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Longitudinal analysis of the monospecific coombs test in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) chronically treated with Eculizumab
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 50
ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Nodular lesions of the scalp and a mediastinal mass in T cell acute lymphoblastic leukemiaIn: International Journal of Hematology Jg. 92 (2010) Nr. 1, S. 3 - 4
ISSN: 1865-3774; 0925-5710Online Volltext: dx.doi.org/ -
Paroxysmal nocturnal hemoglobinuria turning Coombs-positiveIn: International Journal of Hematology Jg. 91 (2010) Nr. 2, S. 159 - 160
ISSN: 1865-3774; 0925-5710Online Volltext: dx.doi.org/ -
Porphyria cutanea tardaIn: British Journal of Haematology Jg. 148 (2010) Nr. 4, S. 493
ISSN: 0007-1048; 1365-2141Online Volltext: dx.doi.org/ -
Paroxysmale nächtliche Hämoglobinurie (PNH) : Pathogenese, Diagnostik und TherapieIn: Deutsche Medizinische Wochenschrift - DMW Jg. 134 (2009) Nr. 9, S. 404 - 409
ISSN: 1439-4413; 0012-0472; 1437-5982Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Telomere Biology in T Cells : An Important Brake on the Road of Their Life Span?In: Clinical leukemia Jg. 3 (2009) Nr. 1, S. 41 - 46
ISSN: 1938-0704Online Volltext: dx.doi.org/ -
Dyskeratosis congenitaIn: British Journal of Haematology Jg. 141 (2008) Nr. 4, S. 412
ISSN: 1365-2141; 0007-1048Online Volltext: dx.doi.org/ -
Paroxysmale nächtliche Hämoglobinurie (PNH) : Aktuelle Diagnostik und TherapieansätzeIn: Arzneimitteltherapie (2008) Nr. 3, S. 96 - 101
ISSN: 0723-6913 -
Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemiaIn: British Journal of Haematology Jg. 143 (2008) Nr. 3, S. 383 - 386
ISSN: 1365-2141; 0007-1048Online Volltext: dx.doi.org/ -
Impact of culture conditions on the proliferative lifespan of human T cells in vitroIn: Cytotherapy : official journal of ISCT, the International Society for Cellular Therapy Jg. 9 (2007) Nr. 1, S. 91 - 98
ISSN: 1477-2566Online Volltext: dx.doi.org/ -
Short telomeres and high telomerase activity in T-cell prolymphocytic leukemiaIn: Leukemia Jg. 21 (2007) Nr. 12, S. 2456 - 2462
ISSN: 0887-6924; 1476-5551Online Volltext: dx.doi.org/ -
The complement inhibitor Eculizumab in paroxysmal nocturnal hemoglobinuriaIn: The New England Journal of Medicine Jg. 355 (2006) Nr. 12, S. 1233 - 1243
ISSN: 1533-4406; 0028-4793Online Volltext: dx.doi.org/ -
Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERTIn: Blood Jg. 106 (2005) Nr. 1, S. 43 - 50
ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/ -
Telomerase is limiting the growth of acute myeloid leukemia cellsIn: Leukemia Jg. 17 (2003) Nr. 12, S. 2410 - 2417
ISSN: 1476-5551Online Volltext: dx.doi.org/ -
Telomerase levels control the lifespan of human T lymphocytesIn: Blood Jg. 102 (2003) Nr. 3, S. 849 - 857
ISSN: 1528-0020Online Volltext: dx.doi.org/ -
C1s-targeted inhibition of classical complement pathway by sutimlimab in cold agglutinin disease (CAD) : Efficacy and safety results from the randomized, placebo (PBO)-controlled phase 3 CADENZA study
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 40 - 41
ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Effect of Pegcetacoplan on Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Pegasus Phase 3 Trial Comparing Pegcetacoplan to Eculizumab
61st Annual Scientific Meeting of the British Society for Haematology, 25–28 April 2021, Virtual,In: British Journal of Haematology Jg. 193 (2021) Nr. S1, S. 198 - 199
ISSN: 1365-2141; 0007-1048Online Volltext: dx.doi.org/ -
Effect of Pegcetacoplan on quality of life in patients with Paroxysmal Nocturnal Hemoglobinuria : Week 48 of PEGASUS phase 3 trial comparing Pegcetacoplan to Eculizumab
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 41 - 42
ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Efficacy and Safety at 48 Weeks of Pegcetacoplan in Adult Paroxysmal Nocturnal Hemoglobinuria Patients with Suboptimal Response to Prior Eculizumab Treatment
Society of Hematologic Oncology 9th Annual Meeting ; September 8–11, 2021, Houston, Texas, USA & Virtual Venue,In: Clinical Lymphoma, Myeloma & Leukemia Jg. 21 (2021) Nr. Suppl. 1, S. S341 - S342
ISSN: 2152-2650; 2152-2669Online Volltext: dx.doi.org/ -
Forty-Eight Week Efficacy and Safety of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria and Suboptimal Response to Prior Eculizumab Treatment
Society for the Advancement of Patient Blood Management 2021 Annual Meeting PBM Rocks! Virtual Meeting,In: Anesthesia & Analgesia Jg. 133 (2021) Nr. 3S, S. 6 - 7
ISSN: 1526-7598; 0003-2999Online Volltext (Open Access) -
Forty-eight week efficacy and safety of pegcetacoplan in adult patients with paroxysmal nocturnal hemoglobinuria and suboptimal response to prior eculizumab treatment
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 169
ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Improvements in Fatigue And Physical Function Evaluated Through Changes in Clinical Outcomes In Paroxysmal Nocturnal Hemoglobinuria : Post-HOC Analyses From The Pegasus StudyIn: Bone Marrow Transplantation Jg. 56 (2021) Nr. Suppl. 1, S. 149 - 150
ISSN: 1476-5365; 0268-3369 -
Improvements in Fatigue and Physical Function Evaluated Through Changes in Clinical Outcomes in Paroxysmal Nocturnal Hemoglobinuria : Post-Hoc Analyses from the PEGASUS Study
61st Annual Scientific Meeting of the British Society for Haematology, 25–28 April 2021, Virtual,In: British Journal of Haematology Jg. 193 (2021) Nr. S1, S. 195
ISSN: 1365-2141; 0007-1048Online Volltext: dx.doi.org/ -
Improvements in Fatigue and Physical Function Evaluated Through Changes in Clinical Outcomes in Paroxysmal Nocturnal Hemoglobinuria : Post-Hoc Analyses from the PEGASUS StudyIn: British Journal of Haematology Jg. 193 (2021) Nr. S1, S. 77 - 232
ISSN: 0007-1048; 1365-2141Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Inhibition of Complement C1S with Sutimlimab in Patients with Cold Agglutinin Disease (CAD) : Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up
48th Congress of the Italian Society of Hematology, 24-27 October 2021, Milan, Italy,In: Haematologica / The Hematology Journal Jg. 106 (2021) Nr. 10, S3: 48th Congress of the Italian Society of Hematology, 24-27 October 2021, S. 107
ISSN: 1592-8721; 0390-6078Online Volltext: dx.doi.org/ (Open Access) -
Interim results of the phase 3 CARDINAL study long-term follow-up: Inhibition of complement C1s with sutimlimab in patients with Cold Agglutinin Disease (CAD)
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 169 - 170
ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Results of the IELSG32 Trial at a Median Follow-Up of 88 Months Demonstrate that Matrix Followed by Autologous Transplant is Associated with Excellent Survival and Neurotolerabilty in Patients with Primary CNS Lymphoma
48th Congress of the Italian Society of Hematology, 24-27 October 2021, Milan, Italy,In: Haematologica / The Hematology Journal Jg. 106 (2021) Nr. 10, S3: 48th Congress of the Italian Society of Hematology, 24-27 October 2021, S. 33
ISSN: 1592-8721; 0390-6078Online Volltext: dx.doi.org/ (Open Access) -
Results of the Pegasus Phase 3 Randomized Trial Demonstrating Superiority of the C3 Inhibitor, Pegcetacoplan, Compared to Eculizumab in Patients with Paroxysmal Nocturnal HemoglobinuriaIn: British Journal of Haematology Jg. 193 (2021) Nr. S1,
ISSN: 1365-2141; 0007-1048Online Volltext: dx.doi.org/ -
Risk Factors for Thrombotic Events in Patients with PNH : A Nested Case-Control Study in the International PNH Registry
61st Annual Scientific Meeting of the British Society for Haematology, 25–28 April 2021, Virtual,In: British Journal of Haematology Jg. 193 (2021) Nr. S1, S. 193 - 194
ISSN: 1365-2141; 0007-1048Online Volltext: dx.doi.org/ -
Sutimlimab, a Complement C1S Inhibitor, Improves Quality of Life in Patients with Cold Agglutinin Disease : Patient-Reported Outcomes Results of the Phase 3 Cardinal Study
48th Congress of the Italian Society of Hematology, 24-27 October 2021, Milan, Italy,In: Haematologica / The Hematology Journal Jg. 106 (2021) Nr. 10, S3: 48th Congress of the Italian Society of Hematology, 24-27 October 2021, S. 111 - 112
ISSN: 1592-8721; 0390-6078Online Volltext: dx.doi.org/ (Open Access) -
The Oral Complement Factor B Inhibitor Iptacopan is Safe and Effective in Improving Hematological Response in Paroxysmal Nocturnal Hemoglobinuria Patients with Poor Response to Eculizumab, even in Monotherapy
48th Congress of the Italian Society of Hematology, 24-27 October 2021, Milan, Italy,In: Haematologica / The Hematology Journal Jg. 106 (2021) Nr. 10, S3: 48th Congress of the Italian Society of Hematology, 24-27 October 2021, S. 106 - 107
ISSN: 1592-8721; 0390-6078Online Volltext: dx.doi.org/ (Open Access) -
Transfusion requirements in adult patients with paroxysmal nocturnal hemoglobinuria with or without a history of bone marrow disorder receiving ravulizumab and eculizumab : results from a phase 3 non-inferiority study extension
61st Annual Scientific Meeting of the British Society for Haematology, 25–28 April 2021, Virtual,In: British Journal of Haematology Jg. 193 (2021) Nr. S1, S. 203 - 204
ISSN: 1365-2141; 0007-1048Online Volltext: dx.doi.org/ -
Cold Agglutinin Disease (CAD) Real World Evidence (CADENCE) registry : Design of the first international, prospective CAD registry
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 180
ISSN: 2296-5270; 2296-5262; 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Final Results of a Prospective, Multicenter, noninterventional Study on thiotepa-based Autologous Hematopoietic Cell Transplantation (ASCT) for CNS or non-CNS Lymphoma
46th Annual Meeting of the European Society for Blood and Marrow Transplantation ; 29 August - 1 September, 2020, Virtual Meeting,In: Bone Marrow Transplantation Jg. 55 (2020) Nr. Suppl. 1, S. 298
ISSN: 1476-5365; 0268-3369Online Volltext: dx.doi.org/ -
LNP023-A New Oral Complement Factor-B Inhibitor Normalizes Hemoglobin in Paroxysmal Nocturnal Hemoglobinuria Patients with Poor Response to Eculizumab, Both as Add-on and Monotherapy
46th Annual Meeting of the European Society for Blood and Marrow Transplantation ; 29 August - 1 September, 2020, Virtual Meeting,In: Bone Marrow Transplantation Jg. 55 (2020) Nr. Suppl. 1, S. 32 - 33
ISSN: 1476-5365; 0268-3369Online Volltext: dx.doi.org/ -
Results from the phase 3 Cardinal study part A : Inhibition of complement C1s with Sutimlimab in patients with Cold Agglutinin Disease (CAD)
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 177
ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Results of the PEGASUS Phase 3 Randomized Trial Demonstrating Superiority of the C3 Inhibitor, Pegcetacoplan, Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria
SOHO 2020, 8th annual meeting of the Society of Hematologic Oncology (virtual event), 9-12 September 2020, Houston,In: Clinical Lymphoma, Myeloma & Leukemia Jg. 20 (2020) Nr. Supplement 1, Proceedings of the Society of Hematologic Oncology 2020 Annual Meeting, S. S216 - S217
ISSN: 2152-2650; 2152-2669Online Volltext: dx.doi.org/ -
Results of the PEGASUS phase 3 randomized trial demonstrating superiority of the C3 inhibitor, pegcetacoplan, compared to eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH)
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 176
ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Results of the pegasus phase III trial for the comparison of pegcetacoplan with eculizumab in patients with paroxysmal nocturnal hemoglobinuriaIn: Haematologica / The Hematology Journal Jg. 105 (2020) Nr. Suppl. 3, S. 110
ISSN: 1592-8721; 0390-6078 -
Sickle Cell Disease (SCD) : a single-centre experience - update
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 180 - 181
ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Think twice : Anemia of chronic disease (ACD) due to angiomatoid fibrous histiocytoma (AFH)
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 181
ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
A phase 3 study of Ravulizumab (ALXN1210) vs. Eculizumab in adults with paroxysmal nocturnal hemoglobinuria currently treated with Eculizumab : subgroup analysis by transfusion history and demographics
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Suppl 4, S. 302
ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
Characterizing C5 Inhibition with the SMART-Ig Anti-hC5 Antibody Crovalimab in PNH Patients Using Free Available Paratopes
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Oralndo, USA,In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 1227 - 1227
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Clonal evolution in eltrombopag-resistant aplastic anemia indicated by a novel mutation in transcripts of the thrombopoietin-receptor MPL : a case report
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Suppl 4, S. 147 - 148
ISSN: 2296-5270; 0378-584X; 2296-5262; 1423-0240Online Volltext: dx.doi.org/ (Open Access) -
Exposure-Response Relationship of the SMART-Ig Anti-hC5 Antibody Crovalimab (SKY59): Results from the Umbrella Phase 1/2 Composer Trial in Healthy Volunteers and PNH Patients
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Oralndo, USA,In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 3745 - 3745
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Inhibition of the Classical Pathway of Complement with Sutimlimab in Chronic Immune Thrombocytopenic Purpura Patients without Adequate Response to Two or More Prior Therapies
61st ASH Annual Meeting and Exposition, 07.-10.12.2019, Orlando, FL,In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 898 - 898
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Receiving Prior Eculizumab Treatment
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Oralndo, USA,In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 2231 - 2231
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Seasonal patterns of anemia, hemolytic markers, healthcare resource utilization, and thromboembolic events in cold agglutinin disease
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Suppl 4, S. 9
ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
Subcutaneous Crovalimab (SKY59) for PNH : COMPOSER long term follow-up
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Suppl 4, S. 245
ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
Transfusion requirements in adult patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibitors receiving Ravulizumab or Eculizumab : results from a phase 3 non-inferiority study
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Suppl 4, S. 97
ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
Antithymocyte Globulin (ATG), CSA and eltrombopag followed by autologous stem cell transplantation in a patient with Very Severe Aplastic Anemia (vSAA) and life-threatening pneumonia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 105
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Identification of patients with classical and/or cryptic dyskeratosis congenita (DKC) by telomere length screening using different percentiles : results from the Aachen telomeropathy registry
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 126 - 127
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Meningococcal-Septicemia and its resolution in a patient with Paroxysmal Nocturnal Hemoglobinuria (PNH) receiving ALXN1210, a complement C5 inhibitor
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 198
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Optimization of dose regimen for ALXN1210, a novel complement C5 inhibitor, in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) : results of 2 phase 1/2 studies
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 128
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Results from a Phase 3, Multicenter, Non-Inferiority Study of Ravulizumab (ALXN1210) Versus Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Currently Treated with Eculizumab
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 625 - 625
ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/ -
Results of a phase 2 study as a rationale for the BELIEVE study, a phase 3, double-blind, randomized, placebo-controlled, multicenter study to determine the efficacy and safety of luspatercept in adult patients (Pts) requiring regular RBC transfusions due to β-Thalassemia (β-Thal)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 128 - 129
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Serologic Response to Meningococcal Vaccination in Patients with Cold Agglutinin Disease (CAD) in the New Era of Complement Inhibition
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 3817 - 3817
ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/ -
Sickle Cell Disease (SCD) : A single-centre experience
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 196 - 197
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Subacute aortic dissection in a patient with Paroxysmal Nocturnal Hemoglobinuria (PNH) on chronic treatment with eculizumab
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 199
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
The SMART Anti-hC5 Antibody (SKY59/RO7112689) Shows Good Safety and Efficacy in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 535 - 535
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Thiotepa-based Autologous hematopoietic stem cell transplantation (ASCT) for CNS or non-CNS lymphoma : first results of a prospective, multicenter, non-interventional study
The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation; Mar 18 - 21, 2018; Lisboa, Portugal,In: Bone Marrow Transplantation Jg. 53 (2018) Nr. Supplement, S. 108 - 109
ISSN: 1476-5365; 0268-3369 -
Thrombotic storm leading to the diagnosis of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 199 - 200
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Veno-venous Extracorporal Membrane Oxygenation (VV-ECMO) in a female patient with Sickle Cell Disease (SCD) and Fulminat Acute Chest Syndrome (ACS) : A case report
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 198
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Eculizumab rescue therapy in ABO-incompatible red blood cell transfusion : a case reportIn: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 138 - 139
ISSN: 2296-5270; 2296-5262 -
G-PCNSL-SG-1 randomized phase III trial of high-dose methotrexate with or without whole brain radiotherapy for primary central nervous system lymphoma : Long-term follow-upIn: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, suppl., S. 8527
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
First results of a phase II study with combined systemic and intrathecal chemotherapy followed by high-dose chemotherapy for CNS relapse of aggressive lymphomas
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 192
ISSN: 0378-584X; 1423-0240; 2296-5270; 2296-5262Online Volltext: dx.doi.org/ -
Impact of Meningeal Dissemination (MD) on outcome in primary CNS Lymphoma in the G-PCNSL-SG1 Trial
11th International Conference on Malignant Lymphoma 15-18 June 2011, Lugano (Switzerland),In: Annals of Oncology Jg. 22 (2011) Nr. Suppl. 4, S. iv92
ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ (Open Access) -
Management of pregnancy in paroxysmal nocturnal hemoglobinuria (PNH) in the era of eculizumab : A case report and updated review
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 67
ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Outbreak - pandemic 2009 influenza A (H1N1) infections in a hematology ward : Clinical presentation and outcome
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 43
ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Prognostic factors and score for response and survival in primary central nervous system lymphoma from a randomized phase III trial
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 296 - 296
ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Prognostic factors and scores for chemotherapy-related toxicity in primary central nervous system lymphoma (PCNSL) treated with high-dose methotrexate (HDMTX) with or without ifosfamide : results from a randomized phase III trial
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 295 - 296
ISSN: 0378-584X; 1423-0240; 2296-5270; 2296-5262Online Volltext: dx.doi.org/ -
Role of bone marrow failure in paroxysmal nocturnal hemoglobinuria (PNH) patients chronically treated with Eculizumab
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 115
ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
DECADE Trial : Inhibition of theterminal complement system using the anti-C5 antibody eculizumab for the treatment of cold agglutinin disease (CAD)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 112
ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Expanded CLL CD8(+) T-Cells Are Driven Into a Senescent KLRG1(+) Effector Memory PhenotypeIn: Blood Jg. 116 (2010) Nr. 21, S. 403
ISSN: 0006-4971; 1528-0020 -
Nodular lesions of the scalp and a mediastinal mass in T-cell acute lymphoblastic leukemia (T-ALL)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 238
ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Telomere length measurement by automated multicolor flow-FISH identifies patients with an inherited Bone Marrow Failure (BMF)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 48 - 49
ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Imetelstat (GRN163L) - Telomerase-Based Cancer TherapyIn: Recent Results in Cancer Research / Schlag, Peter M.; Senn, Hans-Jörg (Hrsg.) 2010, S. 221 - 234
Online Volltext: dx.doi.org/ -
Telomere und Telomerase bei physiologischen und pathologischen Zuständen des hämatopoietischen SystemsDuisburg, Essen (2011) 1 CD-ROM